MedicarePartD.guide

A non-government resource built from CMS public data

CGRP migraine drugs on AARP Medicare Rx Preferred from UHC (S5921-388)

Aimovig, Ajovy, Emgality, Nurtec, Ubrelvy and Qulipta, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Pennsylvania + 1 more
Premium
$121.90/month
Deductible
$130.00, doesn't apply to tier 1 and 2
Change plan

5 of 7 CGRP migraine drugs are covered on this plan. All 5 require prior authorization.

2 aren't on the formulary (Ajovy and Zavzpret).

  • Aimovig
    erenumab
    Covered · prior auth
    from $126.56
    Tier 3
  • Emgality
    galcanezumab
    Covered · prior auth
    from $246.86
    Tier 3
  • Nurtec ODT
    rimegepant
    Covered · prior auth
    $807.60
    Tier 4
  • Ubrelvy
    ubrogepant
    Covered · prior auth
    from $607.90
    Tier 4
  • Qulipta
    atogepant
    Covered · prior auth
    from $402.02
    Tier 4
Not on the formulary
Ajovy, Zavzpret

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $130.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list